Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Ticagrelor in Hematologic Diseases: PACTR202003558059352 Clinical Landscape Report 2026
16 October 2026
PACTR202003558059352 clinical landscape for Hematologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Valoctocogene roxaparvovec in Hemophilia A: NCT04323098 Clinical Landscape Report 2026
16 October 2026
NCT04323098 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ketamine Hydrochloride in Vaso-occlusive crisis: NCT04330183 Clinical Landscape Report 2026
16 October 2026
NCT04330183 clinical landscape for Vaso-occlusive crisis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Voxelotor in Chronic Kidney Diseases: NCT04335721 Clinical Landscape Report 2026
16 October 2026
NCT04335721 clinical landscape for Chronic Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BMS-986337 in Idiopathic Pulmonary Fibrosis: NL-OMON49565 Clinical Landscape Report 2026
16 October 2026
NL-OMON49565 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Batoclimab in Myasthenia Gravis: NCT04346888 Clinical Landscape Report 2026
16 October 2026
NCT04346888 clinical landscape for Myasthenia Gravis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cyclophosphamide in Sickle Cell Trait: NCT04362293 Clinical Landscape Report 2026
16 October 2026
NCT04362293 clinical landscape for Sickle Cell Trait: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Montelukast sodium in Sleep Apnea Syndromes: NCT04351698 Clinical Landscape Report 2026
16 October 2026
NCT04351698 clinical landscape for Sleep Apnea Syndromes: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fludeoxyglucose F-18 in Idiopathic Pulmonary Fibrosis: NCT04362644 Clinical Landscape Report 2026
16 October 2026
NCT04362644 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Giroctocogene fitelparvovec in Hemophilia A: NCT04370054 Clinical Landscape Report 2026
16 October 2026
NCT04370054 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Bexotegrast in Idiopathic Pulmonary Fibrosis: ACTRN12620000536965 Clinical Landscape Report 2026
16 October 2026
ACTRN12620000536965 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Bexotegrast in Idiopathic Pulmonary Fibrosis: ACTRN12620000573954 Clinical Landscape Report 2026
16 October 2026
ACTRN12620000573954 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white…